Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance
Radheshyam Meher, Senior Resident at AIIMS, psoted on LinkedIn:
”Exciting Announcement
I am honored to serve as Guest Editor for a special collection in Cureus on:
“Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance”
This collection will highlight how AI is reshaping every step of the transfusion medicine journey, from innovative donor recruitment and retention strategies to predictive inventory management, AI-driven blood safety and pathogen detection, automated hemovigilance, and advanced clinical decision support.
We welcome original research, reviews, case studies, and perspectives that showcase both technological innovation and real-world applications, while also addressing the ethical and regulatory challenges of AI in healthcare.
Our aim is to bring together a global, interdisciplinary perspective that bridges digital health, transfusion science, and clinical practice, ultimately driving improvements in efficiency, safety, and patient outcomes.
Topics include (but are not limited to):
- AI for donor recruitment and retention
- Predictive analytics for transfusion needs
- Machine learning in inventory management
- Automated hemovigilance and adverse event monitoring
- AI in therapeutic apheresis and cellular therapies
- NLP in transfusion data
- Ethical and regulatory considerations
I invite researchers, clinicians, data scientists, and innovators to submit your work and be part of this forward-looking initiative.
Let’s work together to shape the future of AI in Transfusion Medicine.
Submit here.”
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis